Trial NCT05265208

View at ClinicalTrials.gov 
Org. Study IDs: 2017-02-32-005
Secondary IDs: 2021-001575-16

Last trial update was posted on 2024-04-05

MeSH Interventions

Capecitabine

MeSH Conditions

Cholangiocarcinoma

Other Conditions

Resectable Intrahepatic Cholangiocarcinoma

Stopping Reasons

1st level of sequential inclusion reached

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID